GlaxoSmithKline PLC
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 45.28 |
| 52 Week High | 54.64 |
| 52 Week Low | 40.51 |
| Avg. Daily Vol. (Mil) | 1.63 |
| Beta (3 year) | 0.24 |
| Share Related Items | |
| Mkt Cap (Mil) | 119,742.96 |
| Shares Out (Mil) | 2,644.50 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 4.60 |
| Annual Dividend | 2.08 |
| Payout Ratio | 57.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.91 |
| Total Debt / Equity | 1.11 |
| Valuation Ratios | |
| Price Earnings | 12.60 |
| Price/Sales | 2.68 |
| Price/Book | 6.77 |
| Price/Cash Flow | 10.10 |
| Per Share Data | |
| Earnings | 3.58 |
| Sales | 16.91 |
| Book Value | 6.69 |
| Cash Flow | 4.50 |
| Business Summary | |
|---|---|
| The Company and its subsidiary is engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. | |
| General Information | |
| 980 Great West Road
Brentford, Middles, TW8 9GS |
|
| 0.99999999936235 | |
| www.gsk.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 103000 | |
| CEO: Andrew Witty | |
| Short Interest | |
| Current Month (Mil) | 9.05 |
| Previous Month (Mil) | 10.87 |
| Short Interest Ratio (Days) | 6.00 |
| Management Effectiveness | |
| Return on Equity | 55.40 |
| Return on Assets | 16.30 |
| Return on Investments | 29.00 |
| Profitability | |
| Gross Margin | 81.60 |
| EBIT Margin | 34.20 |
| Profit Margin | 21.90 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas